Satellos Bioscience MSLE
NASDAQ MSLE
$8.55 -0.05 (-0.58%)
As of: Sep 30, 2026 · 3:58 PM EDT

Satellos Bioscience (MSLE) Accounts Payables (2023 - 2026)

Updated

Satellos Bioscience's Accounts Payables was $5.86 million in the quarter ended Jun 30, 2026, up 28.4% from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Accounts Payables (2023 - 2026) Analysis & Trends

As of Dec 31, 2025, Accounts Payables at Satellos Bioscience came in at $4.11 million, up 14.6% from the prior year.

  • In earlier years, Accounts Payables was $3.58 million in the year ended Dec 31, 2024 (+31.1%) and $2.73 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 9.22 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 33.30 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -22.89 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 674.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 429.50 Mn
10 Satellos Bioscience 132.95 Mn 132.95 Mn - 5.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.86 Mn
Mar 31, 2026 4.56 Mn
Dec 31, 2025 4.11 Mn
Dec 31, 2024 3.69 Mn
Dec 31, 2023 2.66 Mn
API Access

Satellos Bioscience Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=MSLE&period=max&api_key=YOUR_API_KEY